CIK 0001892500 · Non-accelerated filer<br>Emerging growth company
Clearmind Medicine Inc.
Sign in to watch- Ticker
- CMND
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Oct 31
- Incorporated
- Canada (Federal Level)
- Entity type
- other
- Phone
- 972-54-5704749
- Business address
- 101-1220 WEST 6TH AVENUE, VANCOUVER, BRITISH COLUMBIA, Canada (Federal Level), V6H1A5
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- EFFECT Other Notice of Effectiveness
- 4 Open-market sale 10% owner sold 22,139 shares at $3.31 ($73,192)
- 6-K Event Report of Foreign Issuer
- 4 Open-market sale 10% owner sold 3,183 shares at $3.32 ($10,568)
- 4 Open-market sale 10% owner sold 2,102 shares at $3.36 ($7,063)
- 6-K Event Report of Foreign Issuer
- POS AM Other Post-effective Amendment for Registration Statement
- 6-K Event Report of Foreign Issuer
- 4 Open-market buy 10% owner bought 2,159,052 shares at $0.15 ($330,335)
- 3 Insider Initial Statement of Ownership
Page 2 of 19 · 373 filings